These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 234035)

  • 21. The role of WR-2721 in radiotherapy and/or chemotherapy.
    Yuhas JM; Spellman JM; Culo F
    Cancer Clin Trials; 1980; 3(3):211-6. PubMed ID: 6254681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of the radioprotector adeturon on radiation injury in mice with Lewis carcinoma of the lung].
    Pantev TP; Mircheva II
    Radiobiologiia; 1987; 27(5):665-70. PubMed ID: 3671683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Use of a mixture of chemical protectors against radiation-induced lesions of the testes].
    Mamina VP; Tregubenko IP
    Radiobiologiia; 1978; 18(1):123-7. PubMed ID: 635141
    [No Abstract]   [Full Text] [Related]  

  • 24. Radiotherapy of experimental lung tumors in the presence and absence of a radioprotective drug, S-2-(3-aminopropylamino)ethylphosphorothioic acid (WR-2721).
    Yuhas JM
    J Natl Cancer Inst; 1973 Jan; 50(1):69-78. PubMed ID: 4692869
    [No Abstract]   [Full Text] [Related]  

  • 25. [Quantitative evaluation of protection of mouse bone marrow by separate and combined use of radioprotectors].
    Pugacheva TN; Ovakimov VG; Iarmonenko SP
    Radiobiologiia; 1973; 13(4):611-4. PubMed ID: 4780340
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies of allogeneic tumor transplants: induced rejection of advanced tumors by immune alteration of recipients.
    Russell PS; Chase CM; Burton RC
    J Immunol; 1983 Feb; 130(2):951-7. PubMed ID: 6336775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Joint use of aminopropylaminoethylthiophosphate with other radioprotective agents].
    Suroegin EV
    Radiobiologiia; 1980; 20(4):595-8. PubMed ID: 6251511
    [No Abstract]   [Full Text] [Related]  

  • 28. [Long-term results of whole-body and partial radiation in conditions of use of a complex of radioprotectors].
    Aĭrapetian GM; Likhachev IuP; Ivashin VA
    Radiobiologiia; 1973; 13(6):868-73. PubMed ID: 4780549
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of chemical radiation-protective agents on rabbit eyes following the exposure to fast neutrons (15 meV neutrons)].
    Neubauer H; Graul EH; Jacobi KW; Rüther W; Kovács G
    Klin Monbl Augenheilkd; 1969 Mar; 154(3):453-8. PubMed ID: 5354422
    [No Abstract]   [Full Text] [Related]  

  • 30. [Combined use of radiosensitizing and protective agents in experimental radiotherapy].
    Magdon E; Schröder E; Iarmonenko SP; Vygodskaia AL; Vinskaia NP
    Med Radiol (Mosk); 1984 Dec; 29(12):29-32. PubMed ID: 6513748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacological potentiation of the radioprotective action of hypoxic hypoxia].
    Ovakimov VG; Iarmonenko SP; Klimova TS
    Radiobiologiia; 1974; 14(6):859-63. PubMed ID: 4532268
    [No Abstract]   [Full Text] [Related]  

  • 32. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity.
    Manda T; Shimomura K; Mukumoto S; Kobayashi K; Mizota T; Hirai O; Matsumoto S; Oku T; Nishigaki F; Mori J
    Cancer Res; 1987 Jul; 47(14):3707-11. PubMed ID: 3594435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [An experimental approach to determining the protective properties of drugs against ionizing radiation in low and sublethal doses].
    Chertkov KS; Glushkov VA; Sbitneva MF; Vernigorova LA; Chotiĭ VG; Maliutina TS
    Radiobiologiia; 1992; 32(5):706-12. PubMed ID: 1448561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of S-2-(3-aminopropylamino)ethylphosphorothioic acid (WR 2721) on intestinal crypt survival. II. Fission neutrons.
    Sigdestad CP; Connor AM; Scott RM
    Radiat Res; 1976 Mar; 65(3):430-9. PubMed ID: 1265205
    [No Abstract]   [Full Text] [Related]  

  • 35. Depletion of extracellular cysteine with hydroxocobalamin and ascorbate in experimental murine cancer chemotherapy.
    Pierson HF; Fisher JM; Rabinovitz M
    Cancer Res; 1985 Oct; 45(10):4727-31. PubMed ID: 4027961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improvement of lung tumor radiotherapy through differential chemoprotection of normal and tumor tissue.
    Yuhas JM
    J Natl Cancer Inst; 1972 Apr; 48(4):1255-7. PubMed ID: 5023684
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of radioprotectors on the body's reactivity when exposed to factors involved in space flight].
    Vorob'ev EI; Efimov VI; Karsanova SK
    Kosm Biol Aviakosm Med; 1982; 16(1):4-12. PubMed ID: 7038290
    [No Abstract]   [Full Text] [Related]  

  • 38. [Chemical radiation protection of rabbit eyes following exposure to 60Co gamma rays].
    Rüther W; Jacobi KW; Kovács G; Graul EH; Neubauer H
    Klin Monbl Augenheilkd; 1969 Feb; 154(2):232-8. PubMed ID: 5354404
    [No Abstract]   [Full Text] [Related]  

  • 39. Mice's brain radioprotection: comparative efficacy of a series of aminothiols and aminothiol precursors.
    Schumacher C; Paul K; Robbe Y; Sicart MT; Subra G; Chanal JL; Delard R; Dubois JB
    Farmaco; 1997 Dec; 52(12):725-7. PubMed ID: 9648276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized clinical trial of topical cysteamine disulfide (cystamine) versus free thiol (cysteamine) in the treatment of corneal cystine crystals in cystinosis.
    Iwata F; Kuehl EM; Reed GF; McCain LM; Gahl WA; Kaiser-Kupfer MI
    Mol Genet Metab; 1998 Aug; 64(4):237-42. PubMed ID: 9758713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.